Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer
Ariad Pharmaceuticals
D Ross Camidge; Hye Ryun Kim; Myung-Ju Ahn; James Chih-Hsin Yang; Ji-Youn Han; Jong-Seok Lee; Maximilian J Hochmair; Jacky Yu-Chung Li; Gee-Chen Chang; Ki Hyeong Lee; Cesare Gridelli; Angelo Delmonte; Rosario Garcia Campelo; Dong-Wan Kim; Alessandra Bearz; Frank Griesinger; Alessandro Morabito; Enriqueta Felip; Raffaele Califano; Sharmistha Ghosh; Alexander Spira; Scott N Gettinger; Marcello Tiseo; Neeraj Gupta; Jeff Haney; David Kerstein; Sanjay Popat